Foothill Ranch, CA (openPR) 15 December 2005

The global diabetes market an aggregate of drugs / medications, devices, diagnostics, therapy and their combinations. Drug-segment taken in insulin and oral medications, the market for insulin is almost exclusively of human insulin together. The segment orally active drug is composed of several classes of substances to change with older classes of losing market share to newcomers, and while the market for drugs to treat diabetes has been slow on new formulations to accept the situation quickly.


Markets

devices for blood glucose monitoring and insulin delivery devices further demonstrate the diversity of market growth between different geographical areas on the penetration of technology and changes in the prevalence of diabetes are predictive of changes in the market. Monitoring devices consist almost entirely of glucose monitors, but other forms of assessment (eg, HbA1c win tests for glucose measurement in the long-term) becomes increasingly important. The market monitor consists of blood sampling devices and measuring instruments to automate the process of calculating the amount of glucose and insulin. Mini-sampling devices are not invasive and realize a higher rate than the technologies now in the individual development account the need for sampling are relatively painless.

2005 Medmarket diligence report on the details of the wound and new products and technologies in the management of type 1 and type 2 diabetes, with products for drug / drugs, devices, diagnostics and therapeutics. Detailed country and region-specific data on market size and forecasts market shares of competitors in the U.S., Japan and major European countries included. The report entitled “Diabetes Management Market, Worldwide, 2005-2015″ is described http://www.mediligence.com/rpt-d500.htm.

Medmarket Diligence provides tactical decision-making solutions in medical technology, medical products and investment. The company publishes Medmarket the newsletter, a monthly analysis of the market impact of new technologies in medicine and dedicated reports on technology markets. For more information, contact Patrick Driscoll at email or by phone 949-859-3401 or toll free (USA). 1-866-820-1357.


P

###
clear = “all”
Diabetes Products